Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,889
datasets available to search
ShareScore release 0.9.0
Dataset results
4,889 results for “Diabetic patients”
Dataset on preferences of patients with diabetes towards EQ-5D-5L health states in Germany
<p>The dataset includes data on preferences of patients with diabetes toward EQ-5D-5L health states in Germany and adjacent codebooks. </p>
ADIPOQ Gene Variants (rs266729, rs2241766, rs1501299) and Acute Myocardial Infarction in Vietnamese Patients with Type 2 Diabetes Mellitus
<p>This data is from a study project about ADIPOQ Gene Variants (rs266729, rs2241766, rs1501299) and Acute Myocardial Infarction in Vietnamese Patients with Type 2 Diabetes Mellitus. The data contains information from 550 patients with their identification removed to ensure confidentiality.</p>
Incidence and predictor of diabetic foot ulcer and its association with change in fasting blood sugar among diabetes mellitus patients at referral hospitals in Northwest Ethiopia, 2021
<p>Abstract</p> <p> </p> <p><strong>Background</strong></p> <p>Diabetes mellitus is one of the global public health problems and fasting blood sugar is an important indicator of diabetes management. Uncontrolled diabetes can lead to diabetic foot ulcers, which is a common and disabling complication. The association between fasting blood glucose level and the incidence of diabetic foot ulcers is rarely considered, and knowing its predictors is good for clinical decision-making. Therefore, the aim of this study was to determine the incidence and predictors of diabetic foot ulcers and its association with changes in fasting blood sugar among diabetes mellitus patients at referral hospitals in Northwest Ethiopia.</p> <p><strong>Methods</strong></p> <p>A multicenter retrospective follow-up study was conducted at a referral hospital in Northwest Ethiopia. A total of 539 newly diagnosed DM patients who had follow-up from 2010 to 2020 were selected using a computer-generated simple random sampling technique. Data was entered using Epi-Data 4.6 and analyzed in R software version 4.1. A Cox proportional hazard with a linear mixed effect model was jointly modeled and 95% Cl was used to select significant variables. AIC and BIC were used for model comparison.</p> <p><strong>Result</strong></p> <p>A total of 539 diabetes patients were followed for a total of 28727.53 person-month observations. Overall, 65 (12.1%) patients developed diabetic foot ulcers with incidence rate of 2.26/1000-person month observation with a 95% CI of [1.77, 2.88]. Being rural (AHR= 2.30, 95%CI: [1.23, 4.29]), being a DM patient with Diabetic Neuropathy (AHR= 2.61, 95%CI: [1.12, 6.06]), and having peripheral arterial disease(PAD) (AHR= 2.96, 95%CI: [1.37, 6.40]) were significant predictors of DFU. The time-dependent lagged value of fasting blood sugar change was significantly associated to the incident of DFU (α = 1.85, AHR=6.35, 95%CI [2.40, 16.79]).</p> <p><strong>Conclusion and recommendation</strong></p> <p>In this study, the incidence of DFU was higher than in previous studies and was influenced by multiple factors like rural residence, having neuropathy, and PAD were significant predictors of the incidence of DFU. In addition, longitudinal changes in fasting blood sugar were associated with an increased risk of DFU. Health professionals and DM patients should give greater attention to the identified risk factors for DFU were recommended.</p>
High Resolution Retinal Blood Vessels Datasets of Diabetic Retinopathy Patients
<p>This dataset contains 89 high resolution image files of blood vessels extracted from publicly available retina images available in DIARETDB1</p>
Multimodal optical measurement for study of lower limb tissue viability in patients with diabetes mellitus
<p>According to the International Diabetes Federation, the challenges of early stage diagnosis and treatment effectiveness monitoring in diabetes is currently one of the highest priorities in modern healthcare. In this experimental study, the potential of combined measurements of skin fluorescence and blood perfusion by the laser Doppler flowmetry method in diagnostics of low limb diabetes complications was evaluated. With the use of Monte Carlo probabilistic modelling, the diagnostic volume and depth of the diagnosis were evaluated. The experimental study involved 76 patients with type 2 diabetes mellitus. These patients were divided into two groups depending on the degree of complications. The control group consisted of 48 healthy volunteers. The local thermal stimulation was selected as a stimulus on the blood microcirculation system. Experimental studies have shown that diabetic patients have elevated values of normalised fluorescence amplitudes, as well as a lower perfusion response to local heating. In the group of people with diabetes with trophic ulcers, these parameters also significantly differ from the control and diabetes only groups. Thus, the intensity of skin fluorescence and level of tissue blood perfusion can act as markers for various degrees of complications from the beginning of diabetes to the formation of trophic ulcers.</p>
Recognition of symptoms, mitigating mechanisms and self-care experiences of type 2 diabetes patients receiving insulin treatment in North-East Ethiopia
<p>Compliance of patients with self-care practices is the mainstay of measures to manage diabetes. Thus, the study explored self-care practices of type 2 diabetes patients receiving insulin treatment in North-East Ethiopia.</p>
Raman spectra of urine from patients with diabetes mellitus and other pathologies
<p>This dataset contains raw (<strong>unprocessed Raman spectra</strong>) of urine from de-identified human patients. Analysis of this dataset is included in our journal article, "<em><strong>Analysis of urine Raman spectra differences from patients with diabetes mellitus and other pathologies</strong></em>." The dataset includes urine Raman spectra from (1) healthy volunteers, (2) patients with chronic kidney disease and diabetes mellitus, (3) patients with chronic kidney disease and without diabetes mellitus, (4) patients with biopsy-confirmed diabetic nephropathy, (5) patients with biopsy-confirmed immune-mediated nephropathy, (5) patients with biopsy-confirmed membranous nephropathy, (6) patients with biopsy-confirmed renal neoplasm, (7) patients with other glomerular pathologies, and (8) Surine (urinalysis control).</p> <p>Raman spectra were obtained with the following parameters:</p> <ul> <li>Raman spectrometer: Agiltron PeakSeeker PRO-785</li> <li>Mode: Bulk liquid scanning</li> <li>Wavelength: 785 nm</li> <li>Wavenumber range: 200-2000 cm-1</li> <li>Laser power: 30 mW</li> <li>Spectral resolution: 8 cm-1</li> <li>Laser spot size: 0.2 mm</li> <li>Excitation time: 30 s</li> </ul> <p>Raman spectral data and de-identified metadata are present in tab-separated value (tsv) files. Each urine sample is bar-code identified and linked to a disease state (or control) in the metadata tsv file. Ten (10) independent Raman scan replicates exist for each urine sample and are identified by bar-code in the spectral data tsv file. The study IRB approval and a sample blank patient consent form are also included here.</p>
Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes
ClinicalTrials.gov study NCT03005288. IPD Sharing: YES. Countries: 2. Publications: 1.
Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine
ClinicalTrials.gov study NCT03874715. IPD Sharing: YES. Countries: 1. Publications: 2.
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin
ClinicalTrials.gov study NCT01499082. IPD Sharing: YES. Countries: 13. Publications: 3.
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
ClinicalTrials.gov study NCT02787551. IPD Sharing: YES. Countries: 9. Publications: 5.
Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT04278417. IPD Sharing: YES. Countries: 16. Publications: 0.
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease
ClinicalTrials.gov study NCT03383627. IPD Sharing: NO. Countries: 1. Publications: 4.
Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy
ClinicalTrials.gov study NCT01499095. IPD Sharing: YES. Countries: 13. Publications: 6.
Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine
ClinicalTrials.gov study NCT03211858. IPD Sharing: YES. Countries: 7. Publications: 3.
Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients
ClinicalTrials.gov study NCT04075513. IPD Sharing: YES. Countries: 7. Publications: 1.
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
ClinicalTrials.gov study NCT03917472. IPD Sharing: YES. Countries: 5. Publications: 1.
Safety and Efficacy of EMA401 in Patients With Painful Diabetic Neuropathy (PDN)
ClinicalTrials.gov study NCT03297294. IPD Sharing: UNDECIDED. Countries: 16. Publications: 1.
A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT02973321. IPD Sharing: YES. Countries: 8. Publications: 2.
VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01528254. IPD Sharing: YES. Countries: 34. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.